10967/276 - QDB Compounds

QsarDB Repository

Zukic, S.; Ivanova, L.; Zusinaite, E.; Merits, A.; Maran, U. Discovery of a Novel Phthalazine-Based VEGFR-2 Inhibitor by Machine Learning Analysis of Diverse Chemical Space with Favorable Pharmacophores and Its Evaluation in Glioblastoma Cell Lines. Results in Chemistry, Under revision

Compound

ID:111
Name:Compound 111
Description:Original numeration in publication: B-1
Labels:Training_set, Nicotinamide-pyridine
CAS:
InChi Code:InChI=1S/C21H18N4O2/c1-15(24-25-21(27)17-6-3-2-4-7-17)16-9-11-19(12-10-16)23-20(26)18-8-5-13-22-14-18/h2-14H,1H3,(H,23,26)(H,25,27)/b24-15+

Properties

pIC50: Negative logarithm of half-maximal inhibitory concentration [-log(uM)]

ValueSource or prediction
7.1

Yousef, R. G.; Ibrahim, A.; Khalifa, M. M. a. E., W. M.; Gobaara, I. M. M.; Mehany, A. B. M. a. E., E. B.; Alsfouk, A. A.; Metwaly, A. M. a. E., I. H. Discovery of new nicotinamides as apoptotic VEGFR-2 inhibitors: virtual screening, synthesis, anti-proliferative, immunomodulatory, ADMET, toxicity, and molecular dynamic simulation studies. J. Enzyme Inhib. Med. Chem. 2022, 37, 1389–1403. https://doi.org/10.1080/14756366.2022.2070744

7.2042

Eq1: VEGFR-2 inhibition (Data used to train model)